Validated antibodies for IHC on human FFPE tissue — with a full datasheet and published study data for each clone.
Search by target protein or clone ID. Full datasheet, representative micrographs, and published performance data for each clone.
TRPS1 (trichorhinophalangeal syndrome type 1) is a GATA-family zinc-finger transcription factor that has emerged as a sensitive immunohistochemical marker of breast origin. It is expressed across all molecular subtypes of breast carcinoma and shows particularly high sensitivity in triple-negative and basal-like disease, where it can exceed the sensitivity of the established marker GATA3. In diagnostic practice, TRPS1 IHC is used to help confirm or exclude a breast primary when evaluating metastatic carcinoma of uncertain origin.
TRPS1 staining is nuclear. As with any single marker, specificity is not absolute — a subset of non-breast tumors, particularly high-grade gynecologic carcinomas, can show TRPS1 positivity — so it is best interpreted as part of an antibody panel and in morphologic context. Anti-TRPS1 clone VB2A2 is a rabbit monoclonal antibody for IHC on formalin-fixed, paraffin-embedded human tissue; its performance in breast and gynecologic tumors has been characterized in the published studies below.
Peer-reviewed and meeting-presented studies on TRPS1 immunohistochemistry, including head-to-head clone comparisons. Full text is available from the original publisher.
For product information, datasheets, or supply inquiries, send a note using the form and we'll reply directly.